| NAME |
LORAZEPAM 2MG/ML CONC,ORAL |
| VA GENERIC NAME |
LORAZEPAM |
| DOSAGE FORM |
SOLN,ORAL |
| FDA MED GUIDE |
Lorazepam_Sol_(Generic)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule IV |
| STRENGTH |
2 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| UNITS |
MG/ML |
| DSS NUMBER |
6 |
| NATIONAL FORMULARY NAME |
LORAZEPAM SOLN,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
LORAZEPAM 2MG/ML ORAL CONCENTRATE |
| VA PRODUCT IDENTIFIER |
L0241 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4002461 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
